ArticleTranslational lung cancer research2024

Comparative efficacy and safety of anlotinib and topotecan as second-line treatment in small cell lung cancer: a retrospective cohort study.

Yang Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.